Safety of CD34(+) Hematopoietic Stem Cells and CD4(+) T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma
在HIV-1感染且患有高危淋巴瘤的患者中，使用LVsh5/C46转导的CD34(+)造血干细胞和CD4(+)T淋巴细胞的安全性
期刊:Molecular Therapy-Methods & Clinical Development
影响因子:4.7
doi:10.1016/j.omtm.2019.02.006
Delville, Marianne; Touzot, Fabien; Couzin, Chloé; Hmitou, Isabelle; Djerroudi, Lounes; Ouedrani, Amani; Lefrère, François; Tuchman-Durand, Caroline; Mollet, Chloé; Fabreguettes, Jean-Roch; Ferry, Nicolas; Laganier, Laurent; Magnani, Alessandra; Magrin, Elisa; Jolaine, Valérie; Saez-Cirion, Asier; Wolstein, Orit; Symonds, Geoffrey; Frange, Pierre; Moins-Teisserenc, Hélène; Chaix-Baudier, Marie-Laure; Toubert, Antoine; Larghero, Jérôme; Parquet, Nathalie; Brignier, Anne C; Barré-Sinoussi, Françoise; Oksenhendler, Eric; Cavazzana, Marina
发育与干细胞
T细胞
HIV
信号转导
炎症/感染
淋巴瘤
微生物学
CD3
CD34
干细胞
细胞生物学
CD4
